Compliance

What Is OASIS-E? A Guide for Home Health Agencies

OASIS-E is the CMS assessment framework for home health. Learn what changed from OASIS-D, how it affects PDGM, and what your agency needs to know.

L

Lime Health Team

Lime Health AI

Understanding OASIS-E

The Outcome and Assessment Information Set (OASIS) is the standardized patient assessment tool that every Medicare-certified home health agency must complete. CMS uses OASIS data for quality measurement, outcome reporting, payment determination under PDGM, and survey oversight.

OASIS-E replaced OASIS-D and introduced significant changes to how agencies document patient status. CMS has since released incremental updates — OASIS-E1 (effective January 1, 2025) and OASIS-E2 (scheduled for 2026) — that refine and expand on the OASIS-E framework. Understanding the core OASIS-E changes and staying current with these updates is essential for maintaining compliance, optimizing reimbursement, and delivering quality care.

What Changed from OASIS-D to OASIS-E

OASIS-E introduced several major updates that affect how clinicians complete assessments and how agencies manage their documentation workflows.

Standardized Patient Assessment Data Elements (SPADEs) — OASIS-E aligns home health assessments with other post-acute settings by incorporating standardized items required under the IMPACT Act. These shared data elements allow CMS to compare patient outcomes across home health, skilled nursing, inpatient rehabilitation, and long-term care hospitals.

Revised Functional Items — The functional assessment sections were restructured to use the GG items (Section GG), which measure self-care and mobility using a standardized coding scale. This replaced many of the legacy ADL/IADL items from previous OASIS versions and changed how clinicians score patient functional status.

Health Equity and Social Determinants — OASIS-E added new items related to health literacy, transportation access, and social isolation. These data points help CMS understand how social determinants of health affect patient outcomes in the home health setting.

Updated Clinical Items — Several clinical assessment areas were revised, including pain assessment, cognitive function screening, and behavioral health items. These updates reflect current clinical best practices and give agencies a more comprehensive view of patient needs.

Removal of Redundant Items — CMS removed or consolidated items that were duplicative or no longer useful for quality measurement, reducing some documentation burden while adding new required elements.

How OASIS-E Affects PDGM

The Patient-Driven Groupings Model (PDGM) uses OASIS data as a primary input for determining payment. Under PDGM, the clinical grouping, functional level, and comorbidity adjustment are all derived from OASIS responses.

With OASIS-E, the functional scoring methodology changed. Agencies that do not properly train clinicians on the new GG item coding conventions risk inaccurate functional scoring, which directly affects the PDGM clinical grouping and, ultimately, reimbursement.

Accurate OASIS-E completion also affects an agency’s standing in CMS quality programs. The Home Health Quality Reporting Program (HH QRP) and the Home Health Value-Based Purchasing (HHVBP) model both rely on OASIS-derived quality measures. Inaccurate assessments can lead to lower quality scores, reduced reimbursement under HHVBP, and increased survey scrutiny.

Key OASIS-E Sections to Focus On

Agencies should pay particular attention to these high-impact areas when training clinicians on OASIS-E:

Section GG: Functional Abilities — This section has the greatest impact on PDGM functional scoring. Clinicians must understand the standardized coding scale and accurately assess what the patient can do safely, not just what they attempt. Overestimating or underestimating functional ability has direct reimbursement consequences.

Clinical Assessment Items — Wound assessment, medication management, and therapy needs all feed into clinical grouping under PDGM. Documentation must be specific and supported by clinical findings in the visit notes.

Discharge Planning Items — OASIS-E discharge items affect quality measures and patient outcome scores. Agencies that complete discharge assessments accurately see better performance on CMS quality metrics.

Social Determinants Items — While these items do not currently affect reimbursement, CMS has signaled their importance for future quality measurement. Completing them accurately now prepares agencies for upcoming changes.

Best Practices for OASIS-E Implementation

Transitioning to OASIS-E successfully requires more than just clinician training on new items. Agencies should take a comprehensive approach.

Build OASIS-E training into your ongoing education program rather than treating it as a one-time rollout. New clinicians, especially those coming from hospital or SNF settings, need to understand the home health-specific context of each OASIS item.

Implement a real-time QA process that catches errors at the point of documentation, not weeks later during a retrospective review. This reduces rework and ensures OASIS responses are consistent with clinical findings.

Use technology to support clinician accuracy. AI-powered OASIS tools can cross-reference clinical notes with OASIS responses, flag inconsistencies, and ensure that documentation supports each data point.

Monitor your OASIS data trends over time. Sudden shifts in functional scoring patterns or clinical grouping distributions can indicate training gaps or documentation issues that need to be addressed.

Getting OASIS-E Right

OASIS-E represents a meaningful evolution in how home health patient assessments are structured and used. Agencies that invest in understanding the changes, training their clinicians, and implementing quality assurance processes will see the benefits in reimbursement accuracy, compliance, and quality performance.

OASIS-E Resources and Tools

Related Articles